Effectiveness of Iranian modified version of CRP in schizophrenia relapse preventio
Not Applicable
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT201106226860N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Diagnosis of schizophrenia, based on DSM-IV-TR criteria; 2. Hospitalization; 3. informed consent; 4. age: 18-65 yr; 5. living with at least one closed family member after discharge; 6. no employment after discharge; 7. living in Tehran or Alborz provinces; 8. Availability; 9.Consent of attending physician; Exclusion criteria: 1. Changing Location; 2. No Consent to enter the study; 3. Failure to participate in more than two thirds of the meetings.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication compliance. Timepoint: months 0, 3, 6, 12. Method of measurement: questionnaires.;Quality of life. Timepoint: months 0, 3, 6, 12. Method of measurement: questionnaires.;Relapse prevention. Timepoint: months 0, 3, 6, 12. Method of measurement: questionnaires.
- Secondary Outcome Measures
Name Time Method Relapse. Timepoint: month 12. Method of measurement: clinical interview and/or hospitalization.